Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-02-22 @ 12:23 PM
Study NCT ID:
NCT02349867
Status:
COMPLETED
Last Update Posted:
2022-09-19
First Post:
2015-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer
Sponsor:
Virginia Commonwealth University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-01-26
First Submit QC Date:
None
Study First Post Date:
2015-01-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-16
Last Update Post Date:
2022-09-19
Last Update Post Date Type:
ACTUAL